FDA
-
-
-
-
-
-
-
iBio Announces Progression of Vaccine Program for Multi-Variant COVID-19 Disease
-
-
-
-
-
-
-
Convalescent Plasma Stocks Surge as FDA Issue Emergency Use Authorization
-
-
-
-
-
-
-
Pre-Open Stock Movers 02/28: (APT) (SGMO) (FTSV) Higher; (BIG) (W) (BYND) Lower (more...)
-
-
-
-
-
-
-
iBio Selects Lead Candidate for its Fibrosis Therapeutics Program
-
-
-
-
-
-
251,739 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All